• 13,446 Abibisika (Black Gold) Points

      Artemisia afra: A potential flagship for African medicinal plants?

      N.Q. Liu, F. Van der Kooy ⁎, R. Verpoorte

      Division of Pharmacognosy, Section of Metabolomics, Institute of Biology, Leiden University,

      PO Box 9502, 2300RA Leiden, The Netherlands

      Abstract

      The genus Artemisia consists of about 500 species, occurring throughout the world. Some very important drug leads have been discovered
      from this genus, notably artemisinin, the well known anti-malarial drug isolated from the Chinese herb Artemisia annua. The genus is also known
      for its aromatic nature and hence research has been focussed on the chemical compositions of the volatile secondary metabolites obtained from
      various Artemisia species. In the southern African region, A. afra is one of the most popular and commonly used herbal medicines. It is used to
      treat various ailments ranging from coughs and colds to malaria and diabetes. Although it is one of the most popular local herbal medicines, only
      limited scientific research, mainly focussing on the volatile secondary metabolites content, has been conducted on this species. The aim of this
      review was therefore to collect all available scientific literature published on A. afra and combine it into this paper. In this review, a general
      overview will be given on the morphology, taxonomy and geographical distribution of A. afra. The major focus will however be on the secondary
      metabolites, mainly the volatile secondary metabolites, which have been identified from this species. In addition all of the reported biological
      activities of the extracts derived from this species have been included as well as the literature on the pharmacology and toxicology. We aim at
      bringing together most of the available scientific research conducted on this species, which is currently scattered across various publications, into
      this review paper.
      © 2008 SAAB.

      Published by Elsevier B.V. All rights reserved.

      Keywords: Artemisia afra; Traditional African Medicine; Volatile secondary metabolites

      Contents

      1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

      86
      2. Botanical aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 186
      2.1. Morphology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

      186
      2.2. Taxonomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

      186
      2.3. Distribution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

      186
      3. Ethnopharmacology and utilization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

      186
      4. Chemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
      4.1. Volatile secondary metabolites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 187
      4.2. Non-volatile secondary metabolites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
      5. Chemical variation in A. afra . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
      6. Biological effect of A. afra extracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
      6.1. Biological activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
      6.2. Spasmolytic properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
      6.3. Cardiovascular effect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
      6.4. Antioxidant activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
      6.5. Sedative and CNS-acting activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .